The $3.5 million grant will go toward the improvement of screening and preventive treatment of cervical cancer for women living with HIV in low-resource countries.
Dr. Robert A. Harrington, a cardiologist and chair of the Department of Medicine at Stanford University, has been named the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University.
A novel compound, developed by College of Veterinary Medicine researchers, that has the potential to starve the bacteria that causes tuberculosis – the world’s second-leading infectious killer – is entering human clinical trials.
Hospitals have begun using “decision support tools” powered by artificial intelligence that can diagnose disease, suggest treatment or predict a surgery’s outcome.
The eighth episode of a podcast hosted by Entrepreneurship at Cornell, Startup Cornell, features Rich Horgan ‘14, founder of Cure Rare Disease, a non-profit biotech company.
A small but significant metabolic difference between human and mouse lung tumor cells has been discovered by Weill Cornell Medicine researchers, explaining a discrepancy in previous study results and pointing toward new strategies for developing cancer treatments.
David Reetz, director of counseling and psychological services at the Rochester Institute of Technology, has been named Cornell’s new director of Counseling and Psychological Services; he will join Cornell in mid-December.
Cancers often release molecules into the bloodstream that pathologically alter the liver, shifting it to an inflammatory state, causing fat buildup and impairing its normal detoxifying functions, according to a study from investigators at Weill Cornell Medicine.
The Tree of Life Center – with 174 units, community and retail space, and a full-service health center and dental clinic – opened on Dec. 9 in Jamaica, Queens.